Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Poseida Therapeutics, Inc. (PSTX)  
$2.83 0.04 (1.39%) as of 4:30 Mon 5/6


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 61,820,000
Market Cap: 174.95(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.62 - $4.13
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Poseida Therapeutics is a clinical-stage biopharmaceutical company. Co.'s chimeric antigen receptor T cell (CAR-T) product candidate includes P-BCMA-101, which is an autologous CAR-T being developed for the treatment of patients with metastatic castrate resistant prostate cancer. Co.'s dual CAR-T allogeneic program candidates include P-CD19CD20-ALLO1, which is an allogeneic, off-the-shelf CAR-T product candidate in preclinical development for B cell leukemia and lymphoma indications and some autoimmune disease. Co.'s gene therapy programs include P-OTC-101, which is an in vivo liver-directed gene therapy candidate for the treatment of ornithine transcarbamylase deficiency.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 2,292,857
Total Buy Value $0 $0 $0 $8,025,000
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 160,696
Total Sell Value $0 $0 $0 $592,808
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 103
  Page 3 of 5  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Malin Life Sciences Holdings Ltd Common director with Issuer   –       –       •   2021-11-30 4 B $6.85 $195,838 D/D 28,592 9,661,184 2.45 -39%     
   Malin Life Sciences Holdings Ltd Common director with Issuer   –       –       •   2021-11-18 4 B $7.18 $511,685 D/D 71,312 9,567,501 2.45 -35%     
   Ingalls Kerry D. Chief Operating Officer   •       –      –    2021-11-17 4 B $7.00 $14,000 D/D 2,000 2,000 2.74 -37%     
   Malin Life Sciences Holdings Ltd Common director with Issuer   –       –       •   2021-11-17 4 B $7.21 $2,021,821 D/D 280,384 9,496,189 2.45 -37%     
   Malin Life Sciences Holdings Ltd Common director with Issuer   –       –       •   2021-11-16 4 B $7.17 $198,383 D/D 27,680 9,215,805 2.45 -39%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-11-08 4 AS $7.09 $134,171 I/I (18,924) 3,358,455 -27%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-10-11 4 OE $9.15 $169,504 D/D 18,525 696,422     -
   Ostertag Eric Chief Executive Officer   •       •       •   2021-10-01 4 AS $7.02 $140,604 I/I (20,029) 3,367,506 -44%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-09-20 4 AS $8.00 $160,020 I/I (20,000) 160,696 -40%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-09-14 4 AS $8.14 $162,712 I/I (20,000) 180,696 -41%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-09-13 4 OE $1.17 $172,729 D/D 21,281 675,415     -
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-09-09 4 OE $1.32 $13,220 D/D 10,000 51,485     -
   Ostertag Eric Chief Executive Officer   •       •       •   2021-09-02 4 AS $8.34 $510,925 I/I (61,262) 3,377,085 -35%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-09-01 4 AS $8.46 $432,721 I/I (51,149) 3,406,384 -30%     
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-08-20 4 AS $8.79 $35,142 D/D (4,000) 41,485 -24%     
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-08-20 4 OE $1.32 $5,288 D/D 4,000 45,485     -
   Ostertag Eric Chief Executive Officer   •       •       •   2021-08-06 4 OE $9.15 $1,017,013 D/D 111,149 654,134     -
   Ostertag Eric Chief Executive Officer   •       •       •   2021-08-03 4 AS $7.99 $159,289 I/I (19,936) 3,430,847 -12%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-08-02 4 AS $8.13 $111,682 I/I (13,737) 3,440,382 -11%     
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-07-28 4 OE $1.32 $26,440 D/D 20,000 41,485     -
   Ostertag Eric Chief Executive Officer   •       •       •   2021-07-02 4 AS $8.90 $245,274 I/I (27,542) 3,446,952 -23%     
   Ostertag Eric Chief Executive Officer   •       •       •   2021-07-01 4 AS $9.77 $200,901 I/I (20,563) 3,460,124 -31%     
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-06-17 4 OE $1.32 $6,610 D/D 5,000 21,485     -
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-06-11 4 AS $9.44 $37,747 D/D (4,000) 16,485 -33%     
   Spear Matthew A. Chief Medical Officer   •       –      –    2021-06-11 4 OE $1.32 $5,288 D/D 4,000 20,485     -
  103 Records found
  1  2  3  4  5   
  Page 3 of 5
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us